Advertisement

Topics

Companies Related to "Scientists show that drugs targeting tumour metabolism will" [Most Relevant Company Matches] RSS

20:54 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Scientists show that drugs targeting tumour metabolism will" found in our extensive corporate database of over 50,000 company records.

Showing "Scientists show that drugs targeting tumour metabolism will" Companies 1–25 of 3,200+

Relevant

Agios Pharmaceuticals, Inc.

Agios is the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Agios has multiple first-in-class programs in cancer metabolism and inborn errors of metabolism advancing toward the clinic, in addition to an active research and discovery pipeline across ...


MISSION Therapeutics Ltd

MISSION Therapeutics was founded in 2011 by a team of scientists including Professor Steve Jackson, Dr Niall Martin, Dr Xavier Jacq and Dr Keith Menear, along with founding institutes Cancer Research Technology and Cambridge University. Its activities are based on the research of Professor Steve Jackson, Professor of Biology at the University of Cambridge and Head of Cancer Research UK Laborator...

Threshold Pharmaceuticals, Inc.

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors. This approach offers broad potential to treat most solid tumors. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effe...


Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of therapeutics based on Metabolic Targeting, a powerful scientific approach that offers broad potential to treat most solid tumors and certain other diseases. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than convention...

International Society for the Study of Xenobiotics

Man's use of xenobiotics dates from antiquity but interest in foreign compound metabolism dates from only the mid-19th century when the knowledge and techniques of organic chemistry were first applied to its study. For nearly a century thereafter biotransformation was generally equated with "detoxication" or the elimination of a compound's biological activity.This view changed in the late 1930s wi...

Digital Health Technology Show

Launching in 2017, The Digital Health Technology Show is the biggest show in Europe for disruptive technology and takes place 7-8 March at ExCeL in London.

Raze Therapeutics

Raze Therapeutics is dedicated to the discovery and development of a new class of oncology therapeutics that target fundamental metabolic pathways essential to cancer growth and survival. By selectively targeting one-carbon (1C) metabolism using its proprietary platform, Raze is developing a pipeline of 1C metabolism therapeutics across a range of solid an...

Show Your Logo, Inc.

Show Your Logo, Inc. offers promotional products for organizations of all sizes. The company’s impressive product line comprises over 700,000 promotional products ranging from corporate gifts and tradeshow giveaways to team apparel and sports fan favorites. Each of the company’s products can be customized with a logo or other artwork. Show Your L...

Hawaii Biotech, Inc.

Hawaii Biotech, Inc. is a privately held biopharmaceutical company focused on vaccine research and development. The company is targeting first world vaccines with potentially large markets and attractive margins: a West Nile vaccine targeting the U.S. and Canada; and a dengue fever vaccine for travelers from first world countries to dengue endemic areas. The Company’s vaccine technology was feat...

Dynamics Inc.

Dynamics Inc., founded in 2007 by Jeff Mullen, designs and manufactures intelligent battery-powered payment devices and advanced payment platforms. The company won the $1M People's Choice Award at DEMO Fall 2010, four Finovate Best of Show awards, and Best in Show for Personal Electronics at the 2011 International CES show. Dynamics investors include Adams...

Industrial Research Limited - UK

IRL Biopharm is a highly skilled contract manufacturing business focused on developing and manufacturing novel secondary metabolites for our growing number of biotech and pharma clients around the globe.The majority of our clients are US-based innovative biotech/pharma companies.The company had focused over the past two years on developingand manufacturing toxic molecules for attachment to tumour-...

Diasome Pharmaceuticals, Inc.

Diasome Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. Based on more than thirty years of research and development in the fields of cell receptor targeting, insulin formulation, and hepatic (liver) glucose metabolism, the companyâ€...

Life Science Pharmaceuticals

Life Science Pharmaceuticals, Inc. (LSP) is a biopharmaceutical company dedicated to developing drugs for cancer and other serious diseases. LSP entered into a strategic collaboration to develop mAb 806 and other cancer therapeutics developed by Lloyd J. Old and the dedicated scientists at the Ludwig Institute for Cancer Research in 2006. An LSP mon...

Esperance Pharmaceuticals, Inc.

Esperance Pharmaceuticals, Inc. is developing a new class of targeted anticancer drugs using its Cationic Lytic Peptide (CLYP(TM)) platform technology. These drug candidates, called targeted membrane-disrupting peptides (tMDPs) and antibody drug conjugates (ADCs), selectively kill cancer cells, including cells known to be resistant to chemotherapeutic drugs, without harming normal cells. Targeting...

HERMES Biosciences

HERMES Biosciences, Inc. was founded in 1998 to develop highly innovative targeted drug delivery technologies for therapeutic and other biomedical applications. The HERMES vision builds upon previous accomplishments by HERMES scientists and others in the development of both liposomes and antibodies as targeting agents. Liposomes have become an important drug delivery system, with several first- an...

Syndexa Pharmaceuticals Corp.

Syndexa is dedicated to the discovery and development of a new generation of small-molecule drugs targeting novel mechanisms for the treatment and prevention of diseases of endoplasmic reticulum (ER) dysfunction which include inflammatory and metabolic diseases and disorders, cardiovascular diseases and neurodegenerative diseases. Founded by leading scient...

Kineta Inc.

Kineta is a Seattle-based privately held biotechnology company specializing in clinical advancement of novel drug candidates derived from leading edge scientific research. Our world-class scientists are pioneers in developing life-changing classes of new drugs designed to be more effective and safer than current medicines. Kineta seeks to improve the lives of millions of people suffering from au...

Athelas SA

Athelas is a drug discovery company developing a novel class of drugs to treat bacterial infectious diseases. Contrary to conventional antibiotics, Athelas’ drugs treat bacterial infections by targeting mechanisms that are essential for bacterial colonization, invasion and survival only when bacteria are within the host’ environment. "

Agios Pharmaceuticals , Inc.

Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class investigational m...

R-Tech Ueno, Ltd.

R-Tech Ueno is a bio-venture company established in September 1989 for the purpose of marketing and R&D of drugs. Under leadership of the president, also a medical doctor, the company is developing new drugs on the theme "Physician-Oriented New Drug Innovation," targeting ophthalmologic and dermatologic diseases that previously had no effective therapeutic agent.

Wearable Technology Show

“The Wearable Technology Show continues to grow from strength to strength, breaking new boundaries in terms of our global audience, reach and content each year,” commented COO John Weir.

Kineta, Inc.

Kineta, Inc. is a Seattle-based privately held biotechnology company specializing in clinical advancement of novel drug candidates derived from leading-edge scientific research. Our world-class scientists are pioneers in developing life-changing classes of new drugs designed to be more effective and safer than current medicines. Kineta seeks to improve the...

NovaDel Pharma Inc.

NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed drugs. The Company’s proprietary technology offers, in comparison to conventional oral dosage forms, the potential for faster absorption of drugs into the bloodstream leading to quicker onset of therapeutic effects and possibly re...

Knockouts Haircuts for Men

Headquartered in Irving, Texas, Knockouts Haircuts for Men is growing at an explosive rate, selling over 450 franchised salons in 26 states. Knockouts has been featured on NBC's Today Show, MSNBC's The Big Idea with Donny Duetsch, Fox News' Neal Cavuto Show and others. For more information, visit Knockouts' Web site at http://www.knockouts.net.

Urigen Holdings Inc

Urigen is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for urological disorders. Urigen has five products in development for urology indications that are either in or positioned to enter Phase 2 clinical trials. The pipeline includes U101, for which a Phase 2b study in on-going for the treatment of Chronic Pelvic Pain (CPP); U102, ta...


More From BioPortfolio on "Scientists show that drugs targeting tumour metabolism will"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks